Ledger.Open graph →
SEC Form D · filed October 28, 2021

Resonant Therapeutics, Inc

Offering
$4.1M
Sold
$2.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Houston, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Dan K. Watkins · Houston, TXDirectorJohn K. Westwick · Santa Barbara, CAExec · DirectorMark E. Murphy · Stamford, CTExec · DirectorDan K. Watkins · Houston, TXDirectorWilliam E. Greener · COHASSET, MADirectorCotrina Stephen · DENVER, COExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗